1. 输入关键词后点击检索按钮可查询指定关键词在语料中的对应情况
  2. 选择语种可限定关键词的语言,当前支持中文和英文,默认选择中文
  3. 主题选项中可限定检索语料的文章主题范围,默认全部主题
  4. 主题选项中可限定检索语料的文本类型范围,默认全部类型
  5. 在结果列表中,点击操作栏中的“查看中文全文”或“查看英文全文”按钮可查看该句所在的中文语料全文
句对齐列表 共 16269 个结果  
序号 中文 英文 操作
1231 证据表明,在死亡率、机械通气需求、临床改善时间以及其他对患者重要的结果方面没有重要影响。 Work on this began on 15 October when the WHO Solidarity Trial published its interim results.
1232 指南制定小组认识到需要开展更多研究,尤其要为特定患者群体提供更确定的证据 The evidence suggested no important effect on mortality, need for mechanical ventilation, time to clinical improvement, and other patient-important outcomes.
1233 *当对干预措施的效益和风险证据不太确定时,会发布有条件的建议。 The guideline development group recognized that more research is needed, especially to provide higher certainty of evidence for specific groups of patients.
1234 这里涉及一条反对使用瑞德西韦的有条件建议。 They supported continued enrollment in trials evaluating remdesivir.
1235 这意味着没有足够的证据支持其使用 Updated 20 November 2020 * A conditional recommendation is issued when the evidence around the benefits and risks of an intervention are less certain.
1236 医疗产品警报2019年第6期 喀麦隆出现伪造氢氯噻嗪(含有格列本脲) Medical Product Alert N° 6/2019: Falsified hydrochlorothiazide Falsified hydrochlorothiazide (containing glibenclamide) in Cameroon
1237 2019年4月17日 | 医疗产品警报 17 April 2019 | Medical product alert
1238 医疗产品警报涉及在世卫组织非洲区域流通的经确认属于伪造氢氯噻嗪 This Medical Product Alert relates to confirmed falsified hydrochlorothiazide that has been found to contain glibenclamide instead of hydrochlorothiazide, circulating in the WHO region of Africa.
1239 已发现这一伪造产品含有格列本脲,而不含氢氯噻嗪. 正宗的氢氯噻嗪被用作抗高血压和利尿药,而格列本脲是一种抗糖尿病药物 Adverse effects attributed to these products have been reported.
1240 喀麦隆一个非政府组织于2019年3月向世界卫生组织通报,一种(50毫克装)氢氯噻嗪药物导致患者出现低血糖 In March 2019, WHO was informed by a nongovernmental organization in Cameroon that a medicine presenting as hydrochlorothiazide 50mg had caused hypoglycaemia in patients.